DuPont   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Wilmington DE United States (1802)
Status: Acquired by Bristol-Myers Squibb (2001)

Organization Overview

First Clinical Trial
1994
NCT00203580
First Marketed Drug
1971
naloxone (narcan)
First NDA Approval
1971
naloxone (narcan)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Dupont Applied Biosciences | DuPont Nutrition and Biosciences | DuPont Nutrition and Health | DuPont nutrition bioscience Aps